Giovanni Amabile

2.5k total citations
28 papers, 1.7k citations indexed

About

Giovanni Amabile is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Giovanni Amabile has authored 28 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 9 papers in Hematology and 3 papers in Oncology. Recurrent topics in Giovanni Amabile's work include Pluripotent Stem Cells Research (9 papers), Epigenetics and DNA Methylation (7 papers) and Renal and related cancers (7 papers). Giovanni Amabile is often cited by papers focused on Pluripotent Stem Cells Research (9 papers), Epigenetics and DNA Methylation (7 papers) and Renal and related cancers (7 papers). Giovanni Amabile collaborates with scholars based in United States, Italy and Singapore. Giovanni Amabile's co-authors include Alexander Meissner, Daniel G. Tenen, Annalisa Di Ruscio, Alexander K. Ebralidze, Meritxell Alberich-Jordà, Pu Zhang, Anna Morena D’Alise, Robert S. Welner, Lorena Lôbo de Figueiredo-Pontes and María E. Figueroa and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Giovanni Amabile

28 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giovanni Amabile United States 17 1.3k 292 276 185 177 28 1.7k
Ryohichi Sugimura Hong Kong 14 902 0.7× 303 1.0× 224 0.8× 147 0.8× 209 1.2× 48 1.4k
Zack Z. Wang United States 20 1.0k 0.8× 129 0.4× 218 0.8× 199 1.1× 180 1.0× 38 1.5k
Soonsang Yoon United States 8 1.2k 0.9× 144 0.5× 152 0.6× 226 1.2× 161 0.9× 10 1.6k
Jason M. Butler United States 15 849 0.7× 323 1.1× 123 0.4× 168 0.9× 240 1.4× 19 1.3k
Annalisa Di Ruscio Italy 19 1.1k 0.9× 343 1.2× 307 1.1× 123 0.7× 83 0.5× 36 1.5k
Garrett C. Heffner United States 11 1.2k 1.0× 198 0.7× 93 0.3× 138 0.7× 187 1.1× 15 1.5k
Motohiko Oshima Japan 23 1.1k 0.9× 536 1.8× 181 0.7× 179 1.0× 93 0.5× 50 1.5k
Thomas Stiehl Germany 21 528 0.4× 404 1.4× 176 0.6× 317 1.7× 109 0.6× 49 1.3k
Michael D. Bettess Australia 8 883 0.7× 253 0.9× 102 0.4× 120 0.6× 106 0.6× 8 1.2k
Viktor Janzen Germany 13 1.2k 0.9× 449 1.5× 199 0.7× 300 1.6× 164 0.9× 24 1.9k

Countries citing papers authored by Giovanni Amabile

Since Specialization
Citations

This map shows the geographic impact of Giovanni Amabile's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giovanni Amabile with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giovanni Amabile more than expected).

Fields of papers citing papers by Giovanni Amabile

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giovanni Amabile. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giovanni Amabile. The network helps show where Giovanni Amabile may publish in the future.

Co-authorship network of co-authors of Giovanni Amabile

This figure shows the co-authorship network connecting the top 25 collaborators of Giovanni Amabile. A scholar is included among the top collaborators of Giovanni Amabile based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giovanni Amabile. Giovanni Amabile is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amabile, Giovanni, et al.. (2025). Clinical applications of oligonucleotides for cancer therapy. Molecular Therapy. 33(6). 2705–2718. 6 indexed citations
2.
Moein, Shiva, Daniel G. Tenen, Giovanni Amabile, & Li Chai. (2022). SALL4: An Intriguing Therapeutic Target in Cancer Treatment. Cells. 11(16). 2601–2601. 14 indexed citations
3.
Gaggi, Giulia, Andrea Di Credico, Pascal Izzicupo, et al.. (2020). Epigenetic Features of Human Perinatal Stem Cells Redefine Their Stemness Potential. Cells. 9(5). 1304–1304. 16 indexed citations
4.
Focosi, Daniele & Giovanni Amabile. (2017). Induced Pluripotent Stem Cell-Derived Red Blood Cells and Platelet Concentrates: From Bench to Bedside. Cells. 7(1). 2–2. 26 indexed citations
5.
Tatetsu, Hiro, Nikki R. Kong, Chong Gao, et al.. (2016). SALL4, the missing link between stem cells, development and cancer. Gene. 584(2). 111–119. 86 indexed citations
6.
Ruscio, Annalisa Di, Francesco Patti, Robert S. Welner, Daniel G. Tenen, & Giovanni Amabile. (2015). Multiple sclerosis: getting personal with induced pluripotent stem cells. Cell Death and Disease. 6(7). e1806–e1806. 18 indexed citations
7.
Amabile, Giovanni, Annalisa Di Ruscio, Fabian Müller, et al.. (2015). Dissecting the role of aberrant DNA methylation in human leukaemia. Nature Communications. 6(1). 7091–7091. 56 indexed citations
8.
Welner, Robert S., Giovanni Amabile, Deepak Bararia, et al.. (2015). Treatment of Chronic Myelogenous Leukemia by Blocking Cytokine Alterations Found in Normal Stem and Progenitor Cells. Cancer Cell. 27(5). 671–681. 97 indexed citations
9.
Ichida, Justin K., Julia TCW, Luis A. Williams, et al.. (2014). Notch inhibition allows oncogene-independent generation of iPS cells. Nature Chemical Biology. 10(8). 632–639. 54 indexed citations
10.
Welner, Robert S., Deepak Bararia, Giovanni Amabile, et al.. (2013). C/EBPα is required for development of dendritic cell progenitors. Blood. 121(20). 4073–4081. 30 indexed citations
11.
Ruscio, Annalisa Di, Alexander K. Ebralidze, Touati Benoukraf, et al.. (2013). DNMT1-interacting RNAs block gene-specific DNA methylation. Nature. 503(7476). 371–376. 384 indexed citations
12.
Ye, Min, Hong Zhang, Giovanni Amabile, et al.. (2013). C/EBPa controls acquisition and maintenance of adult haematopoietic stem cell quiescence. Nature Cell Biology. 15(4). 385–394. 114 indexed citations
13.
Alberich-Jordà, Meritxell, Bas J. Wouters, Martin Balaštík, et al.. (2013). C/EBPγ deregulation results in differentiation arrest in acute myeloid leukemia. Journal of Clinical Investigation. 123(1). 526–526. 1 indexed citations
14.
Amabile, Giovanni, Robert S. Welner, César Nombela‐Arrieta, et al.. (2012). In vivo generation of transplantable human hematopoietic cells from induced pluripotent stem cells. Blood. 121(8). 1255–1264. 160 indexed citations
15.
Alberich-Jordà, Meritxell, Bas J. Wouters, Martin Balaštík, et al.. (2012). C/EBPγ deregulation results in differentiation arrest in acute myeloid leukemia. Journal of Clinical Investigation. 122(12). 4490–4504. 50 indexed citations
16.
Levantini, Elena, Sanghoon Lee, Hanna S. Radomska, et al.. (2011). RUNX1 regulates the CD34 gene in haematopoietic stem cells by mediating interactions with a distal regulatory element. The EMBO Journal. 30(19). 4059–4070. 21 indexed citations
17.
Amabile, Giovanni & Alexander Meissner. (2009). Induced pluripotent stem cells: current progress and potential for regenerative medicine. Trends in Molecular Medicine. 15(2). 59–68. 259 indexed citations
18.
D’Alise, Anna Morena, Giovanni Amabile, Mariangela Iovino, et al.. (2008). Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cells. Molecular Cancer Therapeutics. 7(5). 1140–1149. 115 indexed citations
19.
Amabile, Giovanni, Anna Morena D’Alise, Mariangela Iovino, et al.. (2008). The Aurora B kinase activity is required for the maintenance of the differentiated state of murine myoblasts. Cell Death and Differentiation. 16(2). 321–330. 44 indexed citations
20.
Amabile, Giovanni, Elena Alfani, Alessandro M. Vannucchi, et al.. (2005). Isolation of TPO-dependent subclones from the multipotent 32D cell line. Blood Cells Molecules and Diseases. 35(2). 241–252. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ryohichi Sugimura Breakdown of academic impact, for papers by Zack Z. Wang Breakdown of academic impact, for papers by Soonsang Yoon Breakdown of academic impact, for papers by Jason M. Butler Breakdown of academic impact, for papers by Annalisa Di Ruscio Breakdown of academic impact, for papers by Garrett C. Heffner Breakdown of academic impact, for papers by Motohiko Oshima Breakdown of academic impact, for papers by Thomas Stiehl Breakdown of academic impact, for papers by Michael D. Bettess Breakdown of academic impact, for papers by Viktor Janzen
Rankless by CCL
2026